Lily Martin

ORCID: 0000-0003-0670-866X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Dental Research and COVID-19
  • Suicide and Self-Harm Studies
  • Orthopedic Infections and Treatments
  • Dermatological and COVID-19 studies
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Cancer survivorship and care
  • SARS-CoV-2 and COVID-19 Research
  • Acute Myeloid Leukemia Research
  • Cancer Immunotherapy and Biomarkers
  • Bipolar Disorder and Treatment
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Infectious Diseases and Tuberculosis
  • Medical Imaging and Analysis
  • Spinal Fractures and Fixation Techniques
  • Spine and Intervertebral Disc Pathology
  • Traumatic Brain Injury Research
  • HIV/AIDS oral health manifestations
  • Workaholism, burnout, and well-being
  • Hematological disorders and diagnostics
  • Competitive and Knowledge Intelligence
  • Kruppel-like factors research
  • Personality Disorders and Psychopathology

Queen's University
2024-2025

Icahn School of Medicine at Mount Sinai
2020-2024

NYU Langone Health
2024

Mount Sinai Hospital
2023

Brigham and Women's Hospital
2021-2022

Harvard University
2021-2022

Centre Hospitalier Universitaire de Bordeaux
2021

Mount Sinai Hospital
2021

Hospital Clínic de Barcelona
2021

Hôpital Pellegrin
2021

Patients with immune-mediated diseases treated anti-CD20 monoclonal antibodies may have worse coronavirus disease 2019 (COVID-19) outcomes due to impaired humoral immunity, but differences compared the general population are unknown.We identified patients who received within 1 year prior index date of polymerase chain reaction-confirmed COVID-19 between January 31, 2020, and 2021. General comparators were matched up 5:1 by age, sex, reaction date. Unadjusted multivariable adjusted (for race,...

10.1002/acr2.11386 article EN ACR Open Rheumatology 2021-12-10

To investigate the associations of common MUC5B promoter variant with timing RA-associated interstitial lung disease (RA-ILD) and RA onset.We identified patients meeting 2010 ACR/EULAR criteria available genotype information in Mass General Brigham Biobank, a multihospital biospecimen clinical data collection research study. We determined RA-ILD presence by reviewing all who had CT imaging, biopsy or autopsy results. dates diagnoses manual records review. examined (G>T at rs35705950) RA-ILD,...

10.1093/rheumatology/keac152 article EN Lara D. Veeken 2022-03-15

ABSTRACT Objective The purpose of this study was to validate and provide detailed norms on suicide images commonly used in experimental research, examine whether appraisals varied based image features prior suicidal thoughts behaviors (STBs). Method Young adults ( N = 264) rated the extent which depicted someone “trying kill themselves or who did purpose” (i.e., ratings). Suicide ratings were examined descriptively with bivariate multivariable statistics. Results demonstrated construct...

10.1111/sltb.70010 article EN cc-by-nc-nd Suicide and Life-Threatening Behavior 2025-03-27

COVID-19 patients with rheumatic disease have a higher risk of mechanical ventilation than the general population. The present study was undertaken to assess lung involvement using validated deep learning algorithm that extracts quantitative measure radiographic severity.We performed comparative cohort and ≥1 chest radiograph within ±2 weeks diagnosis matched comparators. We used unadjusted adjusted (for age, Charlson comorbidity index, interstitial disease) quantile regression compare...

10.1002/acr.24883 article EN Arthritis Care & Research 2022-03-21

Martin L., Nourrit A, Durand- Tullou A., Arnal Gaston-Bernard, Jean. Les grottes-citernes des Causses. Le vase a eau et son utilisation. In: Gallia prehistoire, tome 7, 1964. pp. 107-177.

10.3406/galip.1964.1240 article FR Gallia préhistoire 1964-01-01

Abstract Objective Patients with immune-mediated diseases treated CD20 inhibitors may have worse COVID-19 outcomes due to impaired humoral immunity, but differences versus the general population are unknown. Methods We identified patients who received within one year prior index date of PCR-confirmed between January 31, 2020, and 2021. Comparators were matched up 5:1 by age, sex, PCR date. Hazard ratios (HRs) 95% confidence intervals (CIs) for hospitalization, mechanical ventilation, death...

10.1101/2021.08.05.21261643 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-08-09

Abstract Background and Objectives Autoimmune myelofibrosis (AIMF) is a rare cause of bone marrow fibrosis (BMF) occurring in the presence or absence defined autoimmune disease (secondary primary AIMF, sAIMF/pAIMF, respectively). Unlike (PMF), AIMF responds well to immunosuppressive therapy with benign clinical course. Diagnostic criteria for opposition PMF have been lacking, though recent work has helped better characterise molecular pathological features improving diagnostic precision....

10.1111/ejh.14064 article EN European Journal Of Haematology 2023-07-29

Abstract Objective To describe the characteristics of COVID-19 vaccine breakthrough infections among systemic autoimmune rheumatic disease (SARD) patients. Methods We identified SARDs patients in a large healthcare system with vaccination ≥14 days prior to positive SARS-CoV-2 molecular test. Details patient’s SARD, status, and infection were extracted. Results Of 340 confirmed between December 11 th , 2020 (date first approval US) July 30 2021, we 16 infections. Seven (44%) received...

10.1101/2021.08.04.21261618 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-08-05
Coming Soon ...